Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q1 2026 · 10-Q
Revenue$37.06M$37.06M+165.9% vs Q1 2025 Net Income$40.10M$40.10M+17.4% vs Q1 2025 EPS Diluted$0.82$0.82+10.8% vs Q1 2025 Operating Cash Flow$53,440,000+15.0% Free Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
derived
ended Mar 31, 2026 · filed May 4, 2026 · 34 d after period end